Montpellier, February 27th 2025 – Quantum Surgical, manufacturer of the Epione® platform for robotic-assisted percutaneous ablations, is proud to announce the expansion of its Scientific Advisory Board (SAB) with the appointment of Sean Tutton, MD, FSIR, FCIRSE, a board-certified diagnostic and interventional radiologist who specializes in the treatment of cancer and non-cancer related pathologic skeletal fractures at UC San Diego Health. This appointment is a key milestone for Quantum Surgical and the company’s commitment to advancing innovation in robotic-assisted procedures for interventional radiologists and expanding access to patient care.
Interventional oncology has become highly specialized and is rapidly becoming a standard of care for many multidisciplinary cancer programs. Considered the fourth pillar of oncology, the growth of this subspecialty is similar to the evolution of surgical oncology.
“Robotics has long been established in surgical fields such as general surgery, urology, and orthopedics, so its integration into interventional radiology is a natural progression,” said Dr. Sean Tutton.
“Robotic-guided procedures in interventional oncology offer significant value to physicians, but it’s the patients who really gravitate to robotics because there is the perception of the precision, efficacy, and safety,” adds Dr. Tutton.
The Epione platform is an advanced robotic-assisted technology designed for interventional radiologists performing percutaneous ablations of abdominal tumors—a minimally invasive treatment often used with curative intent. It enhances physician support by providing real-time patient monitoring, assisting in planning an optimal trajectory, improving tumor targeting precision, increasing the accuracy of therapy delivery, and offering immediate confirmation of procedural success.
“As we continue to focus on our clinical strategy of robotic-assisted procedures, we are honored with the appointment of Dr. Sean Tutton to expand our SAB of world-renowned experts in interventional oncology. His expertise and insight will support our vision of driving the demand for minimally invasive cancer care in the US market,” says Bertin Nahum, CEO and co-founder of Quantum Surgical.
“We are honored to welcome Dr. Sean Tutton to our SAB,” said Laetitia Messner, Chief Clinical Officer at Quantum Surgical. “His expertise and insights will be invaluable in shaping Quantum Surgical’s clinical strategy and driving the adoption of Epione.”
Quantum Surgical’s Scientific Advisory Board brings together a distinguished, multidisciplinary team of global experts dedicated to advancing robotic-assisted interventional oncology. The board includes:
- Govindarajan Narayanan, MD (USA), Chief of Interventional Oncology at Miami Cardiac and Vascular Institute Miami Cancer Institute, a part of Baptist Health South Florida
- Steven D. Colquhoun, MD (USA), Professor of Surgical Oncology, Wellstar MCG Health Medical Center (Augusta, GA)
- Thierry De Baère, MD (France), Professor and Interventional Radiologist at Gustave Roussy Cancer Center (Villejuif)
- Laurent Milot, MD (France), Professor and Deputy Chief Vascular & Interventional Radiology at the Hospices Civils de Lyon
- Luigi Solbiati, MD, (Italy), Professor of Radiology at Humanitas University (Rozzano – Milan) (Honorary Member)
À propos de Quantum Surgical
Quantum Surgical is a French medical robotics company co-founded in 2017 by Bertin Nahum, CEO. With a dynamic team of over 120 employees, the company is headquartered in Montpellier, France, and has offices in Miami, Florida.
Quantum Surgical was awarded the prestigious Prix Galien USA in 2022, the equivalent of the Nobel Prize for biopharmaceutical research, and joined the governmental French Tech 2030 program in 2023, which supports top emerging actors in disruptive innovation.
The Epione platform is designed to standardize cancer care by enabling earlier and more precise interventional oncology procedures. It is FDA-cleared for CT-guided percutaneous ablation procedures in the abdomen, CE-marked for ablations in the abdomen and lung, and compatible with most ablation devices.
Plus d'informations : www.quantumsurgical.com
Contact presse Quantum Surgical
Stéphanie Moy
s.moy@quantumsurgical.com
Tél : +33 (0)6 32 55 85 48
